title: Alzheimer's drug update.  Harvard researchers help test new drugs that could strike at the root of Alzheimer's disease. Here's where things stand.
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000187:drug effects / Q000378:metabolism*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010446:Peptide Fragments / Q000187:drug effects / Q000378:metabolism*; D014481:United States; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D016229:Amyloid beta-Peptides; D061067:Antibodies, Monoclonal, Humanized; D010446:Peptide Fragments; C078592:amyloid beta-protein (1-40); C550616:solanezumab